Recursion Pharmaceuticals Inc (RXRX)
10.01
-0.04
(-0.40%)
USD |
NASDAQ |
May 15, 16:00
10.14
+0.13
(+1.30%)
Pre-Market: 08:33
Recursion Pharmaceuticals Total Liabilities (Quarterly): 156.70M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 156.70M |
December 31, 2023 | 190.26M |
September 30, 2023 | 192.86M |
June 30, 2023 | 197.74M |
March 31, 2023 | 197.19M |
December 31, 2022 | 215.48M |
September 30, 2022 | 223.50M |
Date | Value |
---|---|
June 30, 2022 | 234.94M |
March 31, 2022 | 240.75M |
December 31, 2021 | 67.41M |
September 30, 2021 | 59.57M |
June 30, 2021 | 55.88M |
March 31, 2021 | 504.97M |
December 31, 2020 | 504.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
55.88M
Minimum
Jun 2021
504.97M
Maximum
Mar 2021
217.29M
Average
197.46M
Median
Total Liabilities (Quarterly) Benchmarks
Eli Lilly and Co | 51.05B |
Absci Corp | 41.12M |
Palatin Technologies Inc | 24.94M |
Oragenics Inc | 1.798M |
Actinium Pharmaceuticals Inc | 44.50M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 557.85M |
Shareholders Equity (Quarterly) | 401.15M |
Debt to Equity Ratio | 0.0028 |
Current Ratio | 4.648 |
Net Debt Paydown Yield | -0.00% |